TFAP2A and type 2 diabetes mellitus: We delineated the emerging evidence highlighting the roles of AP-2 family members in obesity, type 2 diabetes, gastrointestinal dysmotility, and esophageal squamous cell cancer, thereby suggesting a potential therapeutic avenue for these disorders.